March 6, 2014
The Japan Pharmaceutical Manufacturers Association (JPMA) has urged Takeda Pharmaceutical to submit an official report on its improper clinical data use in the promotion of its top-seller blood pressure drug Blopress (candesartan). The request was made on March 4 after...read more